TNXP CIK: 1430306

Tonix Pharmaceuticals Holding Corp.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
189
FY22:
131
FY23:
47.8
FY24:
119
FY25:
229
(positive)
Change from FY21 to FY25
millions USD
FY21:
51.9
FY22:
94.9
FY23:
107
FY24:
43.9
FY25:
48.3
Total assets
Change from FY21 to FY25
millions USD
FY21:
241
FY22:
226
FY23:
154
FY24:
163
FY25:
277

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
21.7
FY22:
18.2
FY23:
18.9
FY24:
18.3
FY25:
30.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.47
FY22:
0.33
FY23:
30.0
FY24:
5.03
FY25:
1.18
(positive)
Change from FY21 to FY25
millions USD
FY21:
219
FY22:
207
FY23:
106
FY24:
140
FY25:
245
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
241
FY22:
226
FY23:
154
FY24:
163
FY25:
277

All amounts in millions USD Data source:SEC EDGAR